{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T02:35:25Z","timestamp":1793500525373,"version":"4.5.0"},"reference-count":27,"publisher":"Japanese Society of Internal Medicine","issue":"24","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2020,12,15]]},"DOI":"10.2169\/internalmedicine.3987-19","type":"journal-article","created":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T22:06:32Z","timestamp":1597183592000},"page":"3195-3200","source":"Crossref","is-referenced-by-count":5,"title":["Disseminated &lt;i&gt;Mycobacterium avium&lt;\/i&gt; Infection Complicated with Chylous Ascites in a Patient with Neutralizing Autoantibodies to Interferon-\u03b3"],"prefix":"10.2169","volume":"59","author":[{"given":"Yusuke","family":"Yamaba","sequence":"first","affiliation":[{"name":"Department of Respiratory Medicine, Nagoya City West Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Takakuwa","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Nagoya City West Medical Center, Japan"},{"name":"Department of Education and Research Center for Advanced Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziren","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Nagoya City West Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manami","family":"Saito","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Nagoya City West Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Kawae","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Nagoya City West Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misuzu","family":"Yoshihara","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Nagoya City West Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiji","family":"Kunii","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Nagoya City West Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Ito","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Allergy and Clinical Immunology, Nagoya City University Graduate School of Medical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Akita","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Nagoya City West Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Adjemian J, Olivier KN, Seitz AE, et al. An official ATS\/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 175: 367-416, 2007."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Shiratsuchi H, Johnson JL, Toba H, Ellner JJ. Strain- and donor-related differences in the interaction of <i>Mycobacterium avium<\/i> with human monocytes and its modulation by interferon-gamma. J Infect Dis 162: 932-938, 1990.","DOI":"10.1093\/infdis\/162.4.932"},{"key":"3","unstructured":"3. Frucht DM, Holland SM. Defective monocyte costimulation for IFN-gamma production in familial disseminated <i>Mycobacterium avium<\/i> complex infection: abnormal IL-12 regulation. J Immunol 157: 411-416, 1996."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Newport MJ, Huxley CM, Huston S, et al. A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. N Engl J Med 335: 1941-1949, 1996.","DOI":"10.1056\/NEJM199612263352602"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Holland SM, Eisenstein EM, Kuhns DB, et al. Treatment of refractory disseminated nontuberculous mycobacterial infection with interferon gamma. A preliminary report. N Engl J Med 330: 1348-1355, 1994.","DOI":"10.1056\/NEJM199405123301904"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6. H\u00f6flich C, Sabat R, Rosseau S, et al. Naturally occurring anti-IFN-gamma autoantibody and severe infections with <i>Mycobacterium cheloneae<\/i> and <i>Burkholderia cocovenenans<\/i>. Blood 103: 673-675, 2004.","DOI":"10.1182\/blood-2003-04-1065"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Smita Y. Patel, Li Ding, Margaret R. Brown, et al. Anti-IFN-gamma autoantibodies in disseminated nontuberculous mycobacterial infections. J Immunol 175: 4769-4776, 2005.","DOI":"10.4049\/jimmunol.175.7.4769"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Kampmann B, Hemingway C, Stephens A, et al. Acquired predisposition to mycobacterial disease due to autoantibodies to IFN-gamma. J Clin Invest 115: 2480-2488, 2005.","DOI":"10.1172\/JCI19316"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Koya T, Tsubata C, Kagamu H, et al. Anti-interferon-gamma autoantibody in a patient with disseminated <i>Mycobacterium avium<\/i> complex. J Infect Chemother 15: 118-122, 2009.","DOI":"10.1007\/s10156-008-0662-8"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Aoki A, Sakagami T, Yoshizawa K, et al. Clinical significance of interferon-\u03b3 neutralizing autoantibodies against disseminated nontuberculous mycobacterial disease. Clin Infect Dis 66: 1239-1245, 2018.","DOI":"10.1093\/cid\/cix996"},{"key":"11","unstructured":"11. Steinemann DC, Dindo D, Clavien PA, Nocito A. Atraumatic chylous ascites: systematic review on symptoms and causes. J Am Coll Surg 212: 899-905, 2011."},{"key":"12","unstructured":"12. Mallick B, Mandavdhare HS, Aggarwal S, Singh H, Dutta U, Sharma V. Mycobacterial chylous ascites: report of three cases and systematic review. Ther Adv Infect Dis 5: 69-75, 2018."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Browne SK, Burbelo PD, Chetchotisakd P, et al. Adult-onset immunodeficiency in Thailand and Taiwan. N Engl J Med 367: 725-734, 2012.","DOI":"10.1056\/NEJMoa1111160"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Shima K, Sakagami T, Tanabe Y, et al. Novel assay to detect increased level of neutralizing anti-interferon gamma autoantibodies in non-tuberculous mycobacterial patients. J Infect Chemother 20: 52-56, 2014.","DOI":"10.1016\/j.jiac.2013.08.003"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Tanaka Y, Hori T, Ito K, Fujita T, Ishikawa T, Uchiyama T. Disseminated <i>Mycobacterium avium complex<\/i> infection in a patient with autoantibody to interferon-gamma. Intern Med 46: 1005-1009, 2007.","DOI":"10.2169\/internalmedicine.46.6452"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Rubin LA, Kurman CC, Fritz ME, et al. Soluble interleukin 2 receptors are released from activated human lymphoid cells <i>in vitro<\/i>. J Immunol 135: 3172-3177, 1985.","DOI":"10.4049\/jimmunol.135.5.3172"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Sugamura K, Fujii M, Kobayashi N, Sakitani M, Hatanaka M, Hinuma Y. Retrovirus-induced expression of interleukin 2 receptors on cells of human B-cell lineage. Proc Natl Acad Sci USA 81: 7441-7445, 1984.","DOI":"10.1073\/pnas.81.23.7441"},{"key":"18","unstructured":"18. Kniep EM, Strelow I, Lohmann-Matthes ML. The monocyte interleukin-2 receptor light chain: production of cell-associated and soluble interleukin-2 receptor by monocytes. Immunology 75: 299-304, 1992."},{"key":"19","unstructured":"19. Rubin LA, Nelson DL. The soluble interleukin-2 receptor: biology, function, and clinical application. Ann Intern Med 113: 619-27, 1990."},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Takahashi S, Setoguchi Y, Nukiwa T, Kira S. Soluble interleukin-2 receptor in sera of patients with pulmonary tuberculosis. Chest 2: 310-314, 1991.","DOI":"10.1378\/chest.99.2.310"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Press OW, Press NO, Kaufman SD. Evaluation and management of chylous ascites. Ann Intern Med 96: 358-364, 1982.","DOI":"10.7326\/0003-4819-96-3-358"},{"key":"22","unstructured":"22. Almakdisi T, Massoud S, Makdisi G. Lymphomas and chylous ascites: review of the literature. Oncologist 10: 632-635, 2005."},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Vasko JS, Tapper RI. The surgical significance of chylous ascites. Arch Surg 95: 355-368, 1967.","DOI":"10.1001\/archsurg.1967.01330150031006"},{"key":"24","unstructured":"24. Koizumi Y, Sakagami T, Minamiguchi H, et al. Chylous ascites, anti-interferon-gamma autoantibody, and angioimmunoblastic T-cell lymphoma: a rare but intriguing connection over <i>Mycobacterium avium<\/i>. Med Microbiol Immunol 208: 33-37, 2019."},{"key":"25","unstructured":"25. Phillips P, Lee JK, Wang C, Yoshida E, Lima VD, Montaner J. Chylous ascites: a late complication of intra-abdominal <i>Mycobacterium avium<\/i> complex immune reconstitution syndrome in HIV-infected patients. Int J STD AIDS 20: 285-287, 2009."},{"key":"26","unstructured":"26. Mallick B, Mandavdhare HS, Aggarwal S, Singh H, Dutta U, Sharma V. Mycobacterial chylous ascites: report of three cases and systematic review. Ther Adv Infect Dis 5: 69-75, 2018."},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Ishii T, Tamura A, Matsui H, et al. Disseminated <i>Mycobacterium avium<\/i> complex infection in a patient carrying autoantibody to interferon-\u03b3. J Infect Chemother 19: 1152-1157, 2013.","DOI":"10.1007\/s10156-013-0572-2"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/59\/24\/59_3987-19\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T16:23:13Z","timestamp":1696522993000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/59\/24\/59_3987-19\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,15]]},"references-count":27,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.3987-19","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,15]]}}}